Oaktree Acquisition Corp III Life Sciences(OACC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 38.83 | EPS (ttm) | 0.27 | Insider Own | 19.52% | Shs Outstand | 19.8M | Perf Week | -0.09% |
| Market Cap | 0.26B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 19.8M | Perf Month | -0.84% |
| Enterprise Value | 0.26B | PEG | - | EPS next Q | - | Inst Own | 98.71% | Short Float | - | Perf Quarter | -0.65% |
| Income | 0.01B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0 | Perf Half Y | 0.66% |
| Sales | 0.00B | P/B | 1.33 | EPS next 5Y | - | ROA | 3.33% | Short Interest | 0.00M | Perf YTD | 0.85% |
| Book/sh | 8.05 | P/C | 222.29 | EPS past 3/5Y | - | ROE | 3.47% | 52W High | -2.38% ($10.93) | Perf Year | 0.67% |
| Cash/sh | 0.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | 3.41% | 52W Low | 1.62% ($10.50) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 39% | Gross Margin | - | Volatility(W/M) | 0.17% 0.18% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.73 | EPS Q/Q | -14.3% | Profit Margin | - | RSI (14) | 43.81 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.73 | Sales Q/Q | - | SMA20 | -0.55% ($10.73) | Beta | 0 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -0.67% ($10.74) | Rel Volume | 0 | Prev Close | $10.72 |
| Employees | 3 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 0.3% ($10.64) | Avg Volume(3M) | 0.05M | Price | $10.67 |
| IPO | 2024/12/16 | Option/Short | No/Yes | Trades | 6 | Volume | 21 | Change | -0.47% |
A special purpose acquisition company (SPAC) seeking a merger target in the life sciences sector. Global alternative investment manager Oaktree is participating as sponsor, exploring biopharmaceutical, medical device, diagnostics, and specialty healthcare services companies as potential merger targets. The company has no operating business and deposits the funds raised through its IPO into a trust account, where they are held until the merger is completed or the company is liquidated.
Over the past 1 year, roughly in the middle
2% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 98.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SPAQ Horizon Kinetics SPAC Active ETF 0.05% 
FAQ
What kind of company is OACC?
OACC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of OACC?
The market cap of OACC is approximately $262M, ranking 3,771 within its sector.
What is the P/E ratio of OACC?
OACC has a P/E ratio of approximately 38.8x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for OACC?
OACC has recorded a 52-week high of $10.93 and a low of $10.50.
